WO1996008270A3 - Method for inhibiting sexually transmitted diseases using magaining antimicrobials or squalamine compounds - Google Patents
Method for inhibiting sexually transmitted diseases using magaining antimicrobials or squalamine compounds Download PDFInfo
- Publication number
- WO1996008270A3 WO1996008270A3 PCT/US1995/011675 US9511675W WO9608270A3 WO 1996008270 A3 WO1996008270 A3 WO 1996008270A3 US 9511675 W US9511675 W US 9511675W WO 9608270 A3 WO9608270 A3 WO 9608270A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- sexually transmitted
- antimicrobials
- magaining
- transmitted diseases
- squalamine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Marine Sciences & Fisheries (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU35125/95A AU3512595A (en) | 1994-09-13 | 1995-09-13 | Method for inhibiting sexually transmitted diseases using magaining antimicrobials or squalamine compounds |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US30547594A | 1994-09-13 | 1994-09-13 | |
US08/305,475 | 1994-09-13 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO1996008270A2 WO1996008270A2 (en) | 1996-03-21 |
WO1996008270A3 true WO1996008270A3 (en) | 1996-05-17 |
WO1996008270A9 WO1996008270A9 (en) | 1996-06-27 |
Family
ID=23180966
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1995/011675 WO1996008270A2 (en) | 1994-09-13 | 1995-09-13 | Method for inhibiting sexually transmitted diseases using magaining antimicrobials or squalamine compounds |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU3512595A (en) |
WO (1) | WO1996008270A2 (en) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5856535A (en) * | 1994-08-18 | 1999-01-05 | Magainin Pharmaceuticals, Inc. | Aminosterol ester compounds |
FR2744453B1 (en) * | 1996-02-05 | 1998-07-10 | Transgene Sa | LIPOPOLYAMINE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, NUCLEIC ACID TRANSFER VECTORS AND PREPARATION METHOD |
US7410959B1 (en) | 2000-07-13 | 2008-08-12 | Genaera Corporation | Therapeutic uses for aminosterol compounds |
AU2911197A (en) * | 1996-05-24 | 1998-01-05 | Imperial College Of Science, Technology And Medicine | Polycationic sterol derivatives as transfection agents |
US6133233A (en) * | 1997-02-18 | 2000-10-17 | Kansas State University Research Foundation | Peptide modulation of reperfusion injury |
NL1008139C2 (en) * | 1998-01-27 | 1999-07-28 | Stichting Tech Wetenschapp | Antimicrobial peptides. |
US6767904B2 (en) | 1998-03-06 | 2004-07-27 | Bringham Young University | Steroid derived antibiotics |
NL1010692C2 (en) * | 1998-12-01 | 2000-06-06 | Stichting Tech Wetenschapp | Antiviral peptides. |
CN102145005A (en) * | 2006-02-01 | 2011-08-10 | 杨百翰大学 | Cationic steroid antimicrobial compositions and methods of use |
WO2007089906A2 (en) * | 2006-02-01 | 2007-08-09 | Brigham Young University | Cationic steroid antimicrobial compositions for treating or preventing herpes infections |
WO2008048340A2 (en) | 2006-02-01 | 2008-04-24 | Brigham Young University | Cationic steroid antimicrobial compositions for treating poxvirus infections |
JP2007314432A (en) * | 2006-05-23 | 2007-12-06 | Japan Science & Technology Agency | New antimicrobial peptide and serum-free medium containing the antimicrobial peptide as active ingredient |
US8729058B2 (en) * | 2009-10-27 | 2014-05-20 | Michael Zasloff | Methods and compositions for treating and preventing viral infections |
WO2011066260A2 (en) | 2009-11-25 | 2011-06-03 | Michael Zasloff | Formulations comprising aminosterols |
US10040817B2 (en) | 2013-10-03 | 2018-08-07 | Enterin Laboratories, Inc. | Methods and compositions for stimulation of the intestinal enteroendocrine system for treating diseases or conditions related to the same |
EP3678671A4 (en) | 2017-09-08 | 2022-12-07 | Enterin, Inc. | Methods for treating sleep disorders, sleep disturbances, and related symptoms using aminosterol compositions |
WO2019234189A1 (en) * | 2018-06-06 | 2019-12-12 | Centro Nacional De Investigaciones Cardiovasculares Carlos Iii (F.S.P.) | Enhanced trained immunity in myeloid cells by ship-1 inhibition |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1988006597A1 (en) * | 1987-03-04 | 1988-09-07 | The United States Of America, As Represented By Th | New synthetic bioactive compounds and method of producing bioactive effect |
WO1993005802A1 (en) * | 1991-09-13 | 1993-04-01 | Magainin Pharmaceuticals Inc. | Biologically active amphiphilic peptide compositions and uses therefor |
WO1993024138A1 (en) * | 1992-06-01 | 1993-12-09 | Magainin Pharmaceuticals, Inc. | Biologically active peptides having n-terminal substitutions |
WO1994005313A1 (en) * | 1992-08-31 | 1994-03-17 | Magainin Pharmaceuticals Inc. | Treatment of gynecological malignancies with biologically active peptides |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL8104929A (en) * | 1980-11-12 | 1982-06-01 | Alza Corp | ANTICHOLINERGIC PREPARATIONS, PREPARATION AND USE THEREOF. |
US4832953A (en) * | 1987-08-13 | 1989-05-23 | Alza Corporation | Method for preventing the formation of a crystalline hydrate in a dispersion of a liquid in a monaqueous matrix |
ATE101511T1 (en) * | 1988-08-02 | 1994-03-15 | Ciba Geigy Ag | MULTI-LAYER PLASTER. |
DE3908431A1 (en) * | 1989-03-15 | 1990-09-27 | Lohmann Therapie Syst Lts | TRANSDERMAL SYSTEM WITH STAGE SUBSTANCE DELIVERY AND USE FOR LOCAL OR SYSTEMIC DISPENSER |
JPH04261119A (en) * | 1991-02-13 | 1992-09-17 | Lintec Corp | Percutaneous absorption-type pharmaceutical preparation |
-
1995
- 1995-09-13 AU AU35125/95A patent/AU3512595A/en not_active Abandoned
- 1995-09-13 WO PCT/US1995/011675 patent/WO1996008270A2/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1988006597A1 (en) * | 1987-03-04 | 1988-09-07 | The United States Of America, As Represented By Th | New synthetic bioactive compounds and method of producing bioactive effect |
WO1993005802A1 (en) * | 1991-09-13 | 1993-04-01 | Magainin Pharmaceuticals Inc. | Biologically active amphiphilic peptide compositions and uses therefor |
WO1993024138A1 (en) * | 1992-06-01 | 1993-12-09 | Magainin Pharmaceuticals, Inc. | Biologically active peptides having n-terminal substitutions |
WO1994005313A1 (en) * | 1992-08-31 | 1994-03-17 | Magainin Pharmaceuticals Inc. | Treatment of gynecological malignancies with biologically active peptides |
Non-Patent Citations (2)
Title |
---|
ABOUDY, Y. ET AL: "Activity of two synthetic amphiphilic peptides and magainin -2 against herpes simplex virus types 1 and 2", INT. J. PEPT. PROTEIN RES. (1994), 43(6), 573-82 * |
CUERVO, JULIO H. ET AL: "The magainins: sequence factors relevant to increased antimicrobial activity and decreased hemolytic activity", PEPT. RES. (1988), 1(2), 81-6 * |
Also Published As
Publication number | Publication date |
---|---|
WO1996008270A2 (en) | 1996-03-21 |
AU3512595A (en) | 1996-03-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1996008270A3 (en) | Method for inhibiting sexually transmitted diseases using magaining antimicrobials or squalamine compounds | |
MY121276A (en) | Use of glp-1 or analogs to abolish catabolic changes after surgery | |
BG107537A (en) | Method for the inhibition of human tnf alpha activity and its application | |
AU8163394A (en) | Treatment of diabetes by administration of myo-inositol | |
AU2176395A (en) | Compositions for treatment of diabetic complications | |
AU1128297A (en) | Composition for treating pain | |
SI0730864T1 (en) | Medicament for treating cardiac inflammatory diseases | |
AU2187992A (en) | Composition and method for disease treatment | |
CA2168963A1 (en) | Drug for prevention and therapy of diseases caused by fibrinoid formation or thrombus formation in the lung and model animals of the diseases | |
AU1298395A (en) | Method of attenuating nerve injury induced pain | |
WO2002053101A3 (en) | Method for treating fibrotic diseases or other indications | |
ZA895263B (en) | Pharmaceutical composition for the prevention of sexually transmitted diseases | |
AU1148897A (en) | Treatment or prevention of anoxic or ischemic brain injury with melatonin-containing compositions | |
WO1997048369A3 (en) | Prophylactic and therapeutic treatment of skin sensitization and irritation | |
WO2000035952A3 (en) | Compounds for control of eating, growth and body weight | |
AU4376396A (en) | Use of andrographolide compounds to treat or prevent pathogenicity of diseases | |
AU5576196A (en) | Human brain sodium-dependent inorganic phosphate cotransport er | |
GB9508443D0 (en) | Biscuit for working racing or sporting dogs | |
AU3263795A (en) | Medicament for treatment or prophylaxis of incontinence | |
AU5713196A (en) | Method for treatment of pain | |
AU3366493A (en) | Device for desinfecting parts of the human body exposed to infection by sexual relations | |
AU5699396A (en) | Compositions for the treatment of skin conditions | |
AU7639796A (en) | Novel drug for relieving pain and promoting the removal of calculi in urolithiasis | |
ZA95908B (en) | A synergistic formulation for treatment of rheumatic diseases | |
AU6922994A (en) | Use of acylcarnitin to treat illnesses caused by aids |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AU CA JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AU CA JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
COP | Corrected version of pamphlet |
Free format text: PAGES 1-56,DESCRIPTION,REPLACED BY NEW PAGES 1-52;PAGES 57-59,CLAIMS,REPLACED BY NEW PAGES 53-55;DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE |
|
122 | Ep: pct application non-entry in european phase |